<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1355">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03089242</url>
  </required_header>
  <id_info>
    <org_study_id>2017024132</org_study_id>
    <nct_id>NCT03089242</nct_id>
  </id_info>
  <brief_title>MicroRNAs in Acute Kidney Injury</brief_title>
  <acronym>MIRAKI</acronym>
  <official_title>MicroRNAs in Acute Kidney Injury (MIRAKI) - a Pilotstudy -</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Profiling of microRNAs and long noncoding RNAs (lncRNAs) in patients undergoing cardiac
      surgery. Analysis: Prediction of acute kidney injury by plasma expression profile of
      microRNAs?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this pilot study we will include 150 patients undergoing cardiac surgery in a German
      university hospital. We will profile microRNA expression in plasma and urine before and at
      several timepoints after surgery. We will use a preselected panel of microRNAs and lncRNAs
      for analysis. Goal is to identify microRNAs/lncRNAs that are able to predict the occurence
      of AKI in these patients.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 15, 2017</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>acute kidney injury</measure>
    <time_frame>1 year</time_frame>
    <description>AKI Stadium II or III following cardiac surgery.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Kidney Injury in Cardiac Surgery - Expression of microRNAs</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observation of microRNA expression</intervention_name>
    <description>no intervention</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiac surgery patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cardiac surgery

        Exclusion Criteria:

          -  preexisting chronic kidney injury

          -  inclusion in another study

          -  pregnancy

          -  Kidney transplantation in history

          -  GFR &lt; 30 ml/min (glomerular filtration rate)

          -  ECLS therapy (extracorporal life support)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Timo Brandenburger, M.D.</last_name>
    <phone>+49211-81</phone>
    <phone_ext>07058</phone_ext>
    <email>timo.brandenburger@med.uni-duesseldorf.de</email>
  </overall_contact>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 20, 2017</lastchanged_date>
  <firstreceived_date>March 20, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Anästhesiologie</investigator_full_name>
    <investigator_title>PD Dr. Timo Brandenburger</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
